144 related articles for article (PubMed ID: 8605329)
1. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.
Gurniak CB; Berg LJ
Blood; 1996 Apr; 87(8):3151-60. PubMed ID: 8605329
[TBL] [Abstract][Full Text] [Related]
2. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.
Park SY; Saijo K; Takahashi T; Osawa M; Arase H; Hirayama N; Miyake K; Nakauchi H; Shirasawa T; Saito T
Immunity; 1995 Dec; 3(6):771-82. PubMed ID: 8777722
[TBL] [Abstract][Full Text] [Related]
3. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells.
Verbsky JW; Bach EA; Fang YF; Yang L; Randolph DA; Fields LE
J Biol Chem; 1996 Jun; 271(24):13976-80. PubMed ID: 8662778
[TBL] [Abstract][Full Text] [Related]
4. JAK3: expression and mapping to chromosome 19p12-13.1.
Safford MG; Levenstein M; Tsifrina E; Amin S; Hawkins AL; Griffin CA; Civin CI; Small D
Exp Hematol; 1997 May; 25(5):374-86. PubMed ID: 9168059
[TBL] [Abstract][Full Text] [Related]
5. Requirement for Jak3 in mature T cells: its role in regulation of T cell homeostasis.
Sohn SJ; Forbush KA; Nguyen N; Witthuhn B; Nosaka T; Ihle JN; Perlmutter RM
J Immunol; 1998 Mar; 160(5):2130-8. PubMed ID: 9498750
[TBL] [Abstract][Full Text] [Related]
6. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
Rane SG; Reddy EP
Oncogene; 1994 Aug; 9(8):2415-23. PubMed ID: 7518579
[TBL] [Abstract][Full Text] [Related]
7. Jak3 activation in human lymphocyte precursor cells.
Sharfe N; Dadi HK; O'Shea JJ; Roifman CM
Clin Exp Immunol; 1997 Jun; 108(3):552-6. PubMed ID: 9182906
[TBL] [Abstract][Full Text] [Related]
8. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells.
Lai KS; Jin Y; Graham DK; Witthuhn BA; Ihle JN; Liu ET
J Biol Chem; 1995 Oct; 270(42):25028-36. PubMed ID: 7559633
[TBL] [Abstract][Full Text] [Related]
9. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells.
Rane SG; Mangan JK; Amanullah A; Wong BC; Vora RK; Liebermann DA; Hoffman B; Graña X; Reddy EP
Blood; 2002 Oct; 100(8):2753-62. PubMed ID: 12351382
[TBL] [Abstract][Full Text] [Related]
11. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3.
Gurniak CB; Thomis DC; Berg LJ
DNA Cell Biol; 1997 Jan; 16(1):85-94. PubMed ID: 9022047
[TBL] [Abstract][Full Text] [Related]
12. [Long-term expansion of T cell progenitors by JAK3 gene transduced primitive hematopoietic cells in vitro].
Zhao SM; Gu XC; Chang NB; Xu XD; Peng MT
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1701-5. PubMed ID: 16854326
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases.
Takahashi T; Shirasawa T
FEBS Lett; 1994 Apr; 342(2):124-8. PubMed ID: 8143863
[TBL] [Abstract][Full Text] [Related]
14. Expression of a gene encoding a unique protein-tyrosine kinase within specific fetal- and adult-derived hematopoietic lineages.
Choi K; Kennedy M; Keller G
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5747-51. PubMed ID: 7685911
[TBL] [Abstract][Full Text] [Related]
15. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.
Saharinen P; Silvennoinen O
J Biol Chem; 2002 Dec; 277(49):47954-63. PubMed ID: 12351625
[TBL] [Abstract][Full Text] [Related]
16. Defective lymphoid development in mice lacking Jak3.
Nosaka T; van Deursen JM; Tripp RA; Thierfelder WE; Witthuhn BA; McMickle AP; Doherty PC; Grosveld GC; Ihle JN
Science; 1995 Nov; 270(5237):800-2. PubMed ID: 7481769
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3.
Brown MP; Nosaka T; Tripp RA; Brooks J; van Deursen JM; Brenner MK; Doherty PC; Ihle JN
Blood; 1999 Sep; 94(6):1906-14. PubMed ID: 10477719
[TBL] [Abstract][Full Text] [Related]
18. Characterization and analysis of the proximal Janus kinase 3 promoter.
Aringer M; Hofmann SR; Frucht DM; Chen M; Centola M; Morinobu A; Visconti R; Kastner DL; Smolen JS; O'Shea JJ
J Immunol; 2003 Jun; 170(12):6057-64. PubMed ID: 12794134
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of Jak3 signaling on alphabeta and gammadelta thymocyte development.
Eynon EE; Livák F; Kuida K; Schatz DG; Flavell RA
J Immunol; 1999 Feb; 162(3):1448-59. PubMed ID: 9973401
[TBL] [Abstract][Full Text] [Related]
20. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]